AI in Bio + Health
AI-powered platforms have the potential to connect dots in biology that previously looked like noise. A universe of new therapies and next-generation diagnostics is on the horizon.
Featured
All AI in Bio + Health News & Content
new Infinite Healthcare: What’s It Worth?
Investing in Counsel Health
Streamlining the Patient Referrals Chain with Trey Holterman
Marc Andreessen: Can Tech Finally Fix Healthcare?
Super Staffing Healthcare, Codifying Compliance, & Scaling Services
Balancing AI Expertise and Industry Acumen in Vertical Applications
AI + a16z with Vijay Pande
Adapting Biopharma to AI: A 2024 Update with Greg Meyers
AI at the Intersection of Bio with Vijay Pande, Surya Ganguli, and Bowen Liu
Why Computer Science Subsumed Biotech
Implementation, Data, Impact of Healthcare AI with Vijay Pande and Julie Yoo
is a cofounder and general partner at the venture capital firm Andreessen Horowitz.
is a former GP and founder of the Bio + Health team at Andreessen Horowitz, focused on the cross-section of biology and computer science.
is a general partner on the Bio + Health team at Andreessen Horowitz, focused on biotech, digital health, and life sciences tools/diagnostics.
is the editorial lead, healthcare, on the Bio + Health team.
Want More Bio+Health?
Insights, analysis, and additional reading on bio and health, and how both are shaping our future.
Want More Bio+Health?
Insights, analysis, and additional reading on bio and health, and how both are shaping our future.